Learn more about Dr. Zhang...
Learn more about Dr. Srinivasan.
Please join us in welcoming Dr. Ping Zhang, new Stadtman TT Investigator in our SBL #CCRNews https://t.co/fy3YKzeehU https://t.co/gd9KDMvWnu
RT @NCI_CCR_SB: What effect does pembrolizumab have on adoptive cell transfer of TIL? Help us answer the question #melanoma https://t.co/TfQN3F9ilo
@NCI_CCR_SB finds oxygen can impair #cancer #immunotherapy in mice @CellCellPress https://t.co/A5QS4UPE4g https://t.co/RhPrKx2djg
RT @slgoff_SB: Adoptive Cell Transfer Yields Durable Responses in Metastatic #Melanoma https://t.co/5poeXW0nUZ #immunotherapy Coverage of 2016 JCO paper!
RT @NCICancerTrials: This #ClinicalTrial combines #immunotherapy and chemotherapy for melanoma: https://t.co/CgNOyYC8Vk @NCIResearchCtr https://t.co/NgDAwopwLS
Sadhana Jackson @NIHBrainTumor getting drugs thru blood-brain barrier against #brain cancer https://t.co/jY2sc0DX3k https://t.co/tpmQSHf1Qt
Dr. Waldmann discusses the second coming of Daclizumab @translationsci https://t.co/1ajieZICFy
Find a Clinical Trial
Clinics at CCR
Explore Our Research
Find a Researcher
Find a Lab/Branch
Training at CCR
Get to Know CCR
For CCR Staff